Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
Status:
Terminated
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
This study is intended to evaluate the safety and feasibility of intramyocardial injection of
allogeneic mesenchymal cells during the Bi-Directional Cavopulmonary Anastomosis (BDCPA)
surgery for hypoplastic left heart syndrome (HLHS) pediatric patients.